Jenny Sundqvist new CEO of InDex Pharmaceuticals
- Monday, October 10, 2022, 7:06
- Finance
- Add a comment
STOCKHOLM, Oct. 10, 2022 /PRNewswire/ — InDex Pharmaceuticals Holding AB (publ) today announced that the Board of Directors has named Jenny Sundqvist as new CEO. Jenny comes from a position as Chief Commercial Officer at Isofol Medical AB and has broad experience from leading positions…
About the Author
adminasapcorp has written 41811 stories on this site.